Eastman Chemical Company reported its fourth‑quarter and full‑year 2025 financial results on January 29, 2026. Revenue for the quarter fell 12% to $1.97 billion, EBIT dropped to $64 million, and adjusted earnings were $134 million, compared with $305 million in the same period a year earlier. Diluted earnings per share were $0.92, while adjusted EPS was $0.75, versus $2.82 and $1.87 for the prior year.
The company’s adjusted EPS of $0.75 narrowly missed the consensus estimate of $0.76 by $0.01, while revenue of $1.97 billion missed the $2.04 billion estimate by $70 million. The modest EPS miss reflects a combination of lower sales volume and mix in the Fibers and Chemical Intermediates segments, as well as a 4% decline in consumer‑discretionary demand. The revenue shortfall is largely attributable to ongoing inventory destocking in acetate tow and a seasonal decline in end‑market demand, which together eroded top‑line growth.
Management highlighted that pricing pressure in the Chemical Intermediates segment and weaker demand in consumer‑discretionary markets were the primary drivers of the revenue decline. Lower selling prices, driven by weak commodity fundamentals, and a shift toward lower‑margin product mix contributed to margin compression. Despite these headwinds, the company achieved $100 million in cost‑reduction savings and reported that the Kingsport methanolysis facility added roughly $60 million of incremental earnings in 2025 versus 2024, underscoring the value of its innovation‑driven growth strategy.
Eastman did not provide a full‑year 2026 adjusted EPS range, citing significant macroeconomic uncertainty. However, it guided for Q1 2026 adjusted EPS between $1.00 and $1.20, indicating a cautious outlook while still expecting a rebound in earnings as the company’s cost‑control initiatives take effect.
After the release, Eastman’s shares fell about 4.3% in after‑market trading. The decline was driven by the revenue miss and the company’s guarded commentary on the macro environment, which investors interpreted as a signal of continued top‑line weakness and uncertainty about near‑term demand.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.